EC Number   |
Inhibitors |
Structure |
|---|
    4.4.1.13 | 1-(4-chlorophenyl)-3-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]urea |
reversible inhibition |
   |
| 4.4.1.13 | 1-[3-(3,4-dichlorophenyl)isoxazol-5-yl]-2-[(4-thiophen-2-ylpyrimidin-2-yl)sulfanyl]ethanone |
reversible inhibition |
|
| 4.4.1.13 | 2,3,5-trifluoro-N-(2-hydrazino-2-oxoethyl)-4-methoxybenzamide |
only poor inhibitor |
|
| 4.4.1.13 | 2-bromobenzyl (9Z)-9-(hydroxyimino)-2,7-dinitro-9H-fluorene-4-carboxylate |
hydrolysis of the oxime to generate hydroxylamine in situ that interacted with the PLP cofactor |
|
| 4.4.1.13 | 3,3,3,-trifluoroalanine |
irreversible |
|
| 4.4.1.13 | 3,3,3,-trifluoroalanine |
- |
|
| 4.4.1.13 | 3,3,3-trifluoro-N-(2-methylphenyl)-2-(trifluoromethyl)propanamide |
reversible inhibition |
|
| 4.4.1.13 | 3,4-dichlorobenzenesulfonohydrazide |
known to interact with the cofactor of PLP enzymes |
|
| 4.4.1.13 | 3,5-diamino-N-(2-hydrazino-2-oxoethyl)benzamide |
- |
|
| 4.4.1.13 | 3-amino-N-(2-hydrazino-2-oxoethyl)naphthalene-2-carboxamide |
only poor inhibitor |
|
